Moodys Investors Service

acquisition magnet

Pharma

BMS, Merck, Amgen, J&J have biggest appetites for M&A: Moody's

Moody's picked the four based on their portfolio challenges, financial standing and public comments about acquisition plans.

Angus Liu Apr 22, 2021 11:00am

Pills in pill container

Coronavirus poses threats to brand demand and generic supply

Feb 13, 2020 11:24am

teva

Teva shares approach 20-year low amid Moody's warning

Aug 15, 2019 11:15am

deal

M&A boom will hit biopharma in 2019, prognosticators predict

Dec 19, 2018 7:50am